Huperzine A Injection

Small-volume injectables Prescription drugs

Category:

Psychiatry series

Product accessories:

Request for quotation

Anti-Counterfeiting Inquiry

Product Description

· Globally original products developed with research participation from multiple academicians.
· Next-generation first-line drug for brain injury protection and treatment
· The world's first ethanol-choline-enhanced injectable formulation for treating organic brain lesions.

Specifications: IML: 0.2mg
Drug category: Western medicine

Indications: Suitable for benign memory impairments, this product enhances patients' abilities in directed memory, associative learning, image recall, recognition of meaningless figures, and portrait memory. It also shows beneficial effects in improving memory deficits caused by dementia and organic brain disorders. Additionally, this product is used in the treatment of myasthenia gravis.

Pharmacology and Toxicology: Huperzine A is a cholinesterase inhibitor that selectively inhibits acetylcholinesterase (ACHE) and easily crosses the blood-brain barrier. It promotes memory recall, enhances memory retention, and strengthens muscle contraction intensity.